Ain’t no mountain high enough: Cancer survivor eyes Mt. Everest after revolutionary treatment
Following more than a decade of treatments, cancer survivor Laurie Adami now plans to tackle...
Following more than a decade of treatments, cancer survivor Laurie Adami now plans to tackle...
An American woman who owes her life to a bespoke cancer treatment is speaking out...
Laurie Adami has had a long and intricate journey with blood cancer, after being diagnosed...
In the battle against blood cancer, chimeric antigen receptor T cell (CAR-T) therapy is proving...
Special Report: A form of immunotherapy that involves modifying a patient’s white blood cells so...
Today, we will acquaint you with the product pipeline of ASX-listed clinical-stage biotechnology company Prescient Therapeutics...
StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each...
When local synthetic antibiotics developer Recce Pharmaceuticals announced they had entered into an antiviral Sars-CoV-2...
Biotech Prescient Therapeutics (ASX: PTX) has successfully raised $7 million to fund an expanded pipeline...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.